#151914

Anti-CLEC2 [AYP2]

Cat. #151914

Anti-CLEC2 [AYP2]

Cat. #: 151914

Unit size: 100 ug

Availability: 3-5 days

Target: C-type lectin-like receptor 2, CLEC1b

Class: Monoclonal

Application: WB

Reactivity: Human papilloma virus

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Steve Watson

Institute: University of Birmingham

Tool Details
Target Details
Applications
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-CLEC2 [AYP2]
  • Clone: AYP2
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 26 kDa
  • Reactivity: Human papilloma virus
  • Host: Mouse
  • Application: WB
  • Description: Patients with rheumatoid arthritis, an inflammatory disease associated with increased microparticle production, have raised plasma levels of microparticles that expressed CLEC-2 but not GPVI. CLEC-2 can be used to monitor platelet-derived microparticles. The observation that microparticles derived from activated platelets retain CLEC-2 but lose GPVI highlights the potential use of measurement of surface expression of platelet receptors to screen for platelet activation in a wide variety of cardiovascular and inflammatory diseases.
  • Immunogen: A recombinant extracellular fragment of human CLEC-2 (aa 68-229), which is the extracellular domain of the protein.
  • Isotype: IgG1 kappa
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Platelets

Target Details

  • Target: C-type lectin-like receptor 2, CLEC1b
  • Molecular weight: 26 kDa
  • Target background: Patients with rheumatoid arthritis, an inflammatory disease associated with increased microparticle production, have raised plasma levels of microparticles that expressed CLEC-2 but not GPVI. CLEC-2 can be used to monitor platelet-derived microparticles. The observation that microparticles derived from activated platelets retain CLEC-2 but lose GPVI highlights the potential use of measurement of surface expression of platelet receptors to screen for platelet activation in a wide variety of cardiovascular and inflammatory diseases.

Applications

  • Application: WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: Hybridomas were cultured at 37? C and 96% relative humidity in air containing 6% CO2. Cells were grown in complete DMEM + Pen/strep + FCS was used at 10%. Cell density: Cells should be kept between 1-2x105 cells/ml and 5x105 cells/ml.
  • Storage conditions: 4° C
  • Shipping conditions: Shipping at 4° C

Related Tools

  • Related tools: Anti-CLEC2 [AYP1]

References

  • Gitz E et al, Blood, 2014. PMID: 25150298